CGM Use in Non-insulin Patients With DM2

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

Also called NCT07128342

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Milwaukee VA Medical Center (from the registry)
Registry
  • NCT NCT07128342
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07128342. Randomized; no masking; primary purpose treatment. Start 2025-11-01 (anticipated); primary completion 2027-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CGM Use in Non-insulin Patients With DM2
Acronym
CGM-DWI
Condition
Diabetes
Condition
Type 2 Diabetes (T2DM)
Condition
Obesity Type 2 Diabetes Mellitus
Condition
Non Insulin Dependent Diabetes Mellitus
Intervention (Device)
CGM Group
Intervention (Device)
FSBG group
Lead sponsor
Milwaukee VA Medical Center (class: US federal agency)

Record details

Record id
cardio:ct-nct07128342
Content hash
d689240520890e192c9f8ad994f8f06383257db7d3736f5562278fa2906cfd01